Korro Bio (KRRO) Other Non-Current Assets (2018 - 2026)
Korro Bio (KRRO) posted Other Non-Current Assets of $2.3 million for Q1 2026, down 5.1% on a QoQ basis from $2.5 million in Q4 2025, and down 26.06% year-over-year from $3.2 million in Q1 2025.
Korro Bio (KRRO) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Korro Bio's Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- Quarterly Other Non-Current Assets fell 26.06% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 26.06% YoY) and the FY2025 annual result came in at $2.5 million, down 11.62% from the prior year.
- Other Non-Current Assets was $2.3 million for Q1 2026 at Korro Bio, down from $2.5 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $3.4 million in Q1 2024 and bottomed at $228000.0 in Q4 2022.
- A 5-year average of $2.4 million and a median of $2.4 million in 2025 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets tumbled 86.58% — and 2023, when it soared 1090.35%.
- Korro Bio's Other Non-Current Assets stood at $228000.0 in 2022, then surged by 1090.35% to $2.7 million in 2023, then advanced by 3.06% to $2.8 million in 2024, then dropped by 11.62% to $2.5 million in 2025, then decreased by 5.1% to $2.3 million in 2026.
- Business Quant data shows KRRO's Other Non-Current Assets at $2.3 million in Q1 2026, $2.5 million in Q4 2025, and $3.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 60,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 104.24 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 14.48 Mn |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | 2.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.35 Mn |
| Dec 31, 2025 | 2.47 Mn |
| Sep 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 3.21 Mn |
| Mar 31, 2025 | 3.17 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 2.11 Mn |
| Jun 30, 2024 | 3.41 Mn |
| Mar 31, 2024 | 3.41 Mn |
| Dec 31, 2023 | 2.71 Mn |
| Jun 30, 2023 | 1.96 Mn |
| Mar 31, 2023 | 1.70 Mn |
| Dec 31, 2022 | 228,000.00 |
| Sep 30, 2022 | 1.70 Mn |
| Jun 30, 2022 | 1.70 Mn |
| Mar 31, 2022 | 1.70 Mn |
| Dec 31, 2021 | 1.70 Mn |
| Sep 30, 2021 | 1.73 Mn |
| Jun 30, 2021 | 1.83 Mn |
| Mar 31, 2021 | 1.82 Mn |